Concepedia

David J. Hallett

DJ

Statistics

Publications

24

Citations

1.2K

H-Index

19

Active since

1995

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Evotec (United Kingdom)

Evotec (Germany)

University of Manchester

David J. Hallett is an author at MSD (UK) Limited (United Kingdom) specializing in pharmacology, medicinal chemistry, and gabaergic pharmacology.

Publications per year

1995–2021

24

Publications

24

Evidence for a Significant Role of α3-Containing GABA<sub>A</sub>Receptors in Mediating the Anxiolytic Effects of Benzodiazepines

Rebecca Dias, Wayne F. A. Sheppard, Rosa Fradley et al. · Journal of Neuroscience · 2005 · 246 citations · Full text

, , +15

Imidazo[1,2<i>-a</i>]pyrimidines as Functionally Selective and Orally Bioavailable GABA<sub>A</sub>α2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders

Simon Goodacre, Leslie J. Street, David J. Hallett et al. · Journal of Medicinal Chemistry · 2005 · 132 citations · Full text

, , +17

8-Fluoroimidazo[1,2-a]pyridine: Synthesis, physicochemical properties and evaluation as a bioisosteric replacement for imidazo[1,2-a]pyrimidine in an allosteric modulator ligand of the GABAA receptor

Alexander C. Humphries, Emanuela Gancia, Myra T. Gilligan et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 115 citations · Full text

, , +17

3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as High Affinity, Selective, and Orally Bioavailable h5-HT<sub>2A</sub> Receptor Antagonists

Michael Rowley, David J. Hallett, Simon Goodacre et al. · Journal of Medicinal Chemistry · 2001 · 109 citations · Full text

, , +16

Differential contribution of GABA <sub>A</sub> receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands

Rosa Fradley, Martin R. Guscott, Sharlene Bull et al. · Journal of Psychopharmacology · 2006 · 55 citations

, , +14

1–5 of 24